We have located links that may give you full text access.
Case Reports
Journal Article
Indirect treatment of peripheral retinal neovascularization.
American Journal of Ophthalmology 1982 January
Indirect (scatter) cryotherapy and photocoagulation treatments successfully obliterated peripheral neovascularization in patients with sickle cell retinopathy and talc retinopathy. Fifteen of 17 neovascular fronds in seven eyes of five patients were obliterated. This type of treatment is analogous to panretinal photocoagulation for diabetic retinopathy. Because low energy levels are used, indirect treatment of peripheral neovascularization may be a safe and effective alternative to focal treatment of feeder vessels.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app